The present invention relates to the use of at least a non-peptidyl compound
as a biological modulator of insulin activity or insulin-related activity, which
compound possesses ionic and hydrophobic chemical moieties spatially located so
as to mimic at least an ionic and hydrophobic amino acid residue of insulin, which
amino acids are associated with the binding of insulin to its receptor.